Solid Biosciences (SLDB) PT Lowered to $5 at Nomura/Instinet on IGNITE-DMD Clinical Hold
Tweet Send to a Friend
Nomura/Instinet analyst Christopher Marai lowered the price target on Solid Biosciences (NASDAQ: SLDB) to $6.00 (from $22.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
